Health · 1 sources covering this

The U.S. government wants to treat any Americans with Ebola outside of the U.S.

The U.S. plans to try to keep Ebola out by keeping citizens who were potentially exposed in Kenya. This has some in Kenya frustrated and others worried it will deter aid workers from helping.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

NPRLean L·1h ago
The U.S. government wants to treat any Americans with Ebola outside of the U.S.
The U.S. plans to try to keep Ebola out by keeping citizens who were potentially exposed in Kenya. This has some in Kenya frustrated and others worried it will deter aid workers from helping.
Read at NPR →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/0e5bbc8a2f93080795ac05343837451644592bd7"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="The U.S. government wants to treat any Americans with Ebola outside of the U.S."></iframe>

The U.S. government wants to treat any Americans with Ebola outside of the U.S.

How 1 sources are covering this

The U.S. government wants to treat any Americans with Ebola outside of the U.S.

More from Health

STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress

STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk

Biotech exec Jeremy Levin on the industry’s strategic turning point

Reader

Trust & legal

Across the network

How 1 sources are covering this

The U.S. government wants to treat any Americans with Ebola outside of the U.S.

More from Health

STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress

STAT+: Biotech veteran Jeremy Levin on why the industry&#8217;s future is secure, but American leadership is at risk

STAT+: Biotech veteran Jeremey Levin on why the industry&#8217;s future is secure, but American leadership is at risk

Biotech exec Jeremy Levin on the industry&#8217;s strategic turning point

Reader

Trust & legal

Across the network

STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk

Biotech exec Jeremy Levin on the industry’s strategic turning point